Design and In Vitro Evaluation of Slow-Release Dosage Form of Pretanide: Utility of β-Cyclodextrin:Cellulose Derivative Combination as a Modified-Release Drug Carrier
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 79 (3) , 244-248
- https://doi.org/10.1002/jps.2600790314
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrinsInternational Journal of Pharmaceutics, 1988
- A controlled-release matrix tablet of furosemide: design, in vitro evaluation, pharmacological and pharmacodynamic evaluationInternational Journal of Pharmaceutics, 1988
- Enhanced dissolution and oral bioavailability of ?-tocopheryl esters by dimethyl-?-cyclodextrin complexationJournal of inclusion phenomena and molecular recognition in chemistry, 1988
- Comparison between rabbits and beagle dogs of sustained-release effect of gelatin microcapsules containing piretanideJournal of Controlled Release, 1987
- Preparation and biopharmaceutical evaluation of gelatin microcapsules of piretanideJournal of Controlled Release, 1985
- A comparative study of the gastrointestinal transit of a pellet and tablet formulationInternational Journal of Pharmaceutics, 1984
- Sustained Release of Theophylline from Hydroxypropylcellulose TabletsJournal of Pharmaceutical Sciences, 1983
- Kinetics and dynamics of furosemide and slow-acting furosemideClinical Pharmacology & Therapeutics, 1982
- Gastrointestinal sites of furosemide absorption in ratsInternational Journal of Pharmaceutics, 1979
- Pharmacokinetics/pharmacodynamics of furosemide in man: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1979